Blood Clots
Cerebral Venous Sinus Thrombosis: A Patient Primer
January 12, 2022 1 min read
This month, we welcome Dr. Gregory Piazza for an overview on cerebral venous sinus thrombosis (CVST), a rare condition that has recently been associated with the Johnson & Johnson COVID-19 vaccine. Dr. Piazza is an Associate Professor of Medicine at Harvard Medical School, Section Head of Vascular Medicine at Brigham and Women’s Hospital, and a member of NATF’s Board of Directors.
In this webinar, Dr. Piazza specifically discusses:
- What CVST is
- Risk factors for CVST
- Signs and symptoms
- Tools used to diagnose CVST
- Treatment strategies
- The prognosis of CVST (how the disease progresses)
Key Takeaways:
- Although rare in the general population, CVST is more common among younger people, women, and patients with blood clotting disorders.
- There are four major syndromes that are typically seen in CVST, including increased pressure in the brain, problems with brain function, seizures, and certain changes in mental status.
- The diagnosis requires recognition of these syndromes + imaging.
- Anticoagulation (a blood thinner) is the key therapy for CVST.
Keep reading
Blood ClotsI’ve been prescribed a blood thinner – now what?
An anticoagulant (often called a “blood thinner”) is a medication that’s used to treat and prevent blood clots.
Read
Blood ClotsAnticoagulant Comparison Chart
Your healthcare provider may prescribe an anticoagulant (sometimes called a blood thinner) after you have a blood clot.
Read
Blood ClotsDoes Flying Increase My Risk for a Clot?
Long-distance travel may raise your stress level, but can it also raise your risk of getting a blood clot?
Read